A locus on chromosome 2 influences the development of acute graft-versus-host disease in a murine model

Bone Marrow Transplantation

Volumn 23, Issue 11, 1999, Pages 1183-1190

  Harper, J M ^a   Slayback, D L ^a   Dobkins, J A ^a   Allen, R D ^a  

^a INDIANA UNIVERSITY   (United States)

Author keywords

Bone marrow transplantation; Graft versus host disease; GVHD

Indexed keywords

BETA 2 MICROGLOBULIN; INTERLEUKIN 1; MINOR HISTOCOMPATIBILITY ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHROMOSOME 1; CHROMOSOME 2; CONTROLLED STUDY; DNA POLYMORPHISM; GENE LOCUS; GRAFT VERSUS HOST REACTION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0033009474     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1701770     Document Type: Article

References (43)

1. Mendonça LLF, Tyndall A. Bone marrow transplantation in the treatment of autoimmune diseases: evolving concepts and early experience. Lupus 1997; 6: 561-563.
2. van Bekkum DW. BMT in experimental autoimmune diseases. Bone Marrow Transplant 1993; 11: 183-187.
3. Perreault C, Roy DC, Fortin C. Immunodominant minor histocompatibility antigens: the major ones. Immunol Today 1998; 19: 69-73.
4. den Haan JMM., Sherman NE, Blokland E et al. Identification of a graft versus host disease-associated human minor histocompatibility antigen. Science 1995; 268: 1476-1482.
5. Martin PJ. How much benefit can be expected from matching for minor antigens in allogeneic marrow transplantation? Bone Marrow Transplant 1997; 20: 97-100.
6. Turner DM, Williams DM, Sankaran D, Lazarus M. An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet 1997; 24: 1-8.
7. Walley AJ, Cookson WOCM. Investigation of an interleukin-4 promoter polymorphism for associations with asthma and atopy. J Med Genet 1996; 33: 689-692.
8. Bailly S, di Giovine FS, Blakemore AIF, Duff GW. Genetic polymorphism of human interleukin-1α. Eur J Immunol 1993; 23: 1240-1245.
9. Bailly S, di Giovine FS, Duff GW. Polymorphic tandem repeat region in interleukin-1α intron 6. Hum Genet 1993; 91: 85-86.
10. Bioque G, Crusius JBA, Koutroubakis I et al. Allelic polymorphism in IL-1β and IL-1 receptor antagonist (IL-1Ra) genes in inflammatory bowel disease. Clin Exp Immunol 1995; 102: 379-383.
11. Clay FE, Tarlow JK, Cork MJ et al. Novel interleukin-1 receptor antagonist exon polymorphisms and their use in allele-specific mRNA assessment. Hum Genet 1996; 97: 723-726.
12. Verjans GMGM, Messer G, Weiss EH et al. Polymorphism of the tumor necrosis factor region in relation to disease: an overview. Rheumatic Dis Clin N Am 1992; 18: 177-186.
13. Salmon JE, Edberg JC, Brogle NL, Kimberly RP. Allelic polymorphisms of human Fc receptor IIA and Fc gamma receptor IIIB. Independent mechanisms for differences in human phagocyte function. J Clin Invest 1992; 89: 1274-1281.
14. Pociot F, Molvig J, Wogensen L et al. A Taq1 polymorphism in the human interleukin-1β (IL-1β) gene correlates with IL-1β secretion in vitro. Eur J Clin Invest 1992; 22: 396-402.
15. Lazarus M, Hajeer AH, Turner D et al. Genetic variation in the interleukin-10 gene promoter and systemic lupus erythematosus. J Rheumatol 1997; 24: 2314-2317.
16. Metcalfe KA, Hitman GA, Pociot F et al. An association between type 1 diabetes and the interleukin-1 receptor type 1 gene. Hum Immunol 1996; 51: 41-48.
17. Turner D, Grant SCD, Yonan N et al. Cytokine gene polymorphism and heart transplant rejection. Transplantation 1997; 64: 776-779.
18. Turner DM, Grant SCD, Lamb WR et al. A genetic marker of high TNF-α production in heart transplant recipients. Transplantation 1995; 60: 1113-1117.
19. Via CS, Rus V, Gately MK, Finkelman FD. IL-12 stimulates the development of acute graft-versus-host disease in mice that normally would develop chronic, autoimmune graft-versus-host disease. J Immunol 1994; 153: 4040-4047.
20. Via CS, Shearer GM. T-cell interactions in autoimmunity: insights from a murine model of graft-versus-host disease. Immunology 1988; 9: 207-213.
21. Goldman M, Druet P, Gleichman E. TH2 cells in systemic autoimmunity: insights from allogeneic diseases and chemically-induced autoimmunity. Immunol Today 1991; 12: 223-227.
22. Garlisi GC, Pennline KJ, Smith SR et al. Cytokine gene expression in mice undergoing chronic graft-versus-host disease. Mol Immunol 1993; 30: 669-677.
23. Allen RD, Dobkins JA, Harper JM, Slayback DL. Genetics of graft-vs-host disease. I. A locus on chromosome 1 influences development of acute GVHD in an MHC-mismatched murine model. Immunology 1999; 96: 254-261.
24. Allen RD, Slayback DL, Harper JM, Dobkins JA. A locus closely linked to Mtv7 on mouse chromosome 1 influences development of acute vs chronic GVHD (submitted).
25. Miconnet I, Roger T, Seman M, Bruley-Rosset M. Critical role of endogenous Mtv in acute lethal graft-versus-host disease. Eur J Immunol 1995; 25: 364-368.
26. Jones MS, Riley R, Hamilton BL et al. Endogenous superantigens in allogeneic bone marrow transplant recipients rapidly and selectively expand donor T cells which can produce IFN-gamma. Bone Marrow Transplant 1994; 14: 725-735.
27. Biancone L, Andres G, Ahn H et al. Distinct regulatory roles of lymphocyte costimulatory pathways on T helper type-2 mediated autoimmune disease. J Exp Med 1996; 183: 1473-1481.
28. Mouse Genome Database (MGD), Mouse Genome Informatics, The Jackson Laboratory, Bar Harbor, Maine. World Wide Web (URL: http://www.informatics.jax.org/).
29. Manly K. Map manager QT. World Wide Web (URL: http://mctio.med.buffalo.edu/mmQT.html). March 1998.
30. Churchill GA, Doerge RW. Empirical threshold values for quantitative trait mapping. Genetics 1994; 138: 963-971.
31. 1 killer cells. A non-H-2 locus determines the inability to induce lethal graft-versus-host disease. J Exp Med 1981; 153: 1474-1488.
32. Michaelson J. Genetic polymorphism of β2-microglobulin (β2m) maps to the H-3 region of chromosome 2. Immunogenet 1981; 13: 167-171.
33. Michaelson J, Rothenberg E, Boyse EA. Genetic polymorphism of murine β2-microglobulin detected biochemically. Immunogenet 1980; 11: 93-95.
34. 2-microglobulin: structural evidence for strain-related polymorphism. Proc Natl Acad Sci USA 1981; 78: 554-558.
35. 2-microglobulin restriction of antigen presentation. Nature 1990; 346: 751-754.
36. 2-microglobulin. Transplantation 1996; 61: 299-304.
37. Zuberi AR, Nguyen HQ, Auman HJ et al. A genetic linkage map of mouse Chromosome 2 extending from thrombospondin to paired box gene 1, including the H3 minor histocompatibility complex. Genomics 1996; 33: 75-84.
38. Blazar BR, Roopenian DC, Taylor PA et al. Lack of GVHD across classical minor histocompatibility (miH) locus barriers in mice. Transplantation 1996; 61: 619-624.
39. Huang D, Pirksanen R, Hjelmström P, Lefvert AK. Polymorphisms in IL-1β and IL-1 receptor antagonist genes are associated with myasthenia gravis. J Neuroimmunol 1998; 81: 76-81.
40. Ferrara JLM, Abhyankar S, Gilliland DG. Cytokine storm of graft-verus-host disease: a critical effector role for interleukin-1. Transplant Proc 1993; 25: 1216-1217.
41. Abhyankar S, Gilliland DG, Ferrara JLM. Interleukin-1 is a critical effector molecule during cytokine dysregulation in graft-versus-host disease to minor histocompatibility antigens. Transplantation 1993; 56: 1518-1523.
42. Ferrara JLM. Advances in GVHD: novel lymphocyte subsets and cytokine dysregulation. Bone Marrow Transplant 1992; 10 (Suppl. 1): 10-12.
43. McCarthy PL, Abhyankar S, Neben S et al. Inhibition of interleukin-1 by an interleukin-1 receptor antagonist prevents graft-versus-host disease. Blood 1991; 78: 1915-1918.